This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Income of Edwards Lifesciences Corporation with missing and latest data points interpolated. Net income is one of the most important fundamental items in finance. It plays a large role in Edwards Lifesciences financial statement analysis. It represents the amount of money remaining after all of Edwards Lifesciences Corporation operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income, and before the deduction of Preferred Dividends.
|10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Edwards Lifesciences Net Income Over Time